Kawasaki Disease

The following factors may contribute to the development of Kawasaki disease:

1. Age: Children under 5 are most susceptible.
2. Gender: Boys are more commonly affected than girls.
3. Ethnicity: The disease is more prevalent in children of Asian descent, particularly Japanese and Korean.
4. Family history: Children with a family history of Kawasaki disease are at higher risk, with a twofold increase in likelihood.
5. Fever: Prolonged fever (lasting more than 8 days) can trigger an overactive immune response, increasing the risk.
6. Seasonal variation: Kawasaki disease cases are more common during late winter and early spring.

Kawasaki disease is diagnosed when a child exhibits a persistent fever lasting for more than 5 days, accompanied by at least four of the following five clinical signs:

Conjunctival Involvement

• Redness in both eyes (bilateral)
• Painless, without any discharge (non-exudative)

Lymph Node Enlargement

• Swollen lymph nodes in the neck, typically larger than 1.5 cm
• Usually affects one side (unilateral)

Skin Rash

• A red, raised rash (maculopapular) is often present

Changes in Extremities

• Acute Phase: Redness and swelling in the hands and/or feet
• Subacute Phase: Peeling skin around the nails (periungual desquamation)

Mucosal Alterations

• Red, dry, and cracked lips
• "Strawberry tongue," where the tongue appears red and swollen, covered with enlarged taste buds
• Redness in the mouth or throat (diffuse erythema of the oral mucosa or oropharynx)

Other diagnostic methods include:

Imaging Tests

• Echocardiogram: This test uses ultrasound to evaluate the heart’s function and detect any cardiac abnormalities associated with Kawasaki disease.
• Electrocardiogram (ECG): An ECG monitors electrical activity in the heart, helping to detect irregular heart rhythms or other heart-related issues.

Blood Tests

• Complete Blood Count (CBC): Kawasaki disease typically shows a reduced red blood cell count, elevated white blood cell count, and signs of inflammation.
• Erythrocyte Sedimentation Rate (ESR): High ESR levels in the blood can indicate the presence of inflammation.
• C-reactive Protein (CRP): Elevated CRP levels are a sign of inflammation in the body and are commonly seen in Kawasaki disease.
• Serum Electrolytes: This test detects imbalances in components like sodium, albumin, and serum protein, which may occur in Kawasaki disease.
• Liver Function Tests (LFT): Evaluating liver enzymes helps identify any liver involvement due to inflammation.

Urinalysis

• This test checks for any kidney abnormalities and signs of inflammation.

Cerebrospinal Fluid Evaluation

• In Kawasaki disease, cerebrospinal fluid typically shows increased lymphocytes (pleocytosis) but normal levels of protein and glucose.

There is no known way to prevent Kawasaki disease. However, certain practices can support overall health and potentially reduce the likelihood of developing the disease:

Maintain Good Hygiene

• Encourage regular handwashing, especially before meals and after using the restroom, to help prevent infections that could trigger Kawasaki disease or worsen its symptoms.

Stay Up-to-Date with Vaccinations

• Ensure that your child receives all recommended vaccinations to help protect against infections associated with Kawasaki disease. However, the exact relationship between vaccines and Kawasaki disease is still under research.

Specialists to Consult

Several specialists can aid in the treatment of Kawasaki disease:

• General Physician: A general physician can identify early symptoms and refer the child to a specialist for further diagnosis and treatment.
• Pediatrician: A pediatrician diagnoses and treats Kawasaki disease in children, often initiating the right course of action.
• Pediatric Cardiologist: This specialist focuses on heart-related complications arising from Kawasaki disease.
• Pediatric Infectious Disease Specialist: An infectious disease expert diagnoses and manages infections related to Kawasaki disease, ensuring appropriate care.
• Pediatric Rheumatologist: A pediatric rheumatologist can help manage the inflammatory response in Kawasaki disease, reducing symptoms and preventing complications.

Treatment for Kawasaki disease typically involves medications aimed at reducing inflammation and preventing complications. The main treatments include:

Intravenous Immunoglobulin (IVIG)

• IVIG is a concentrated dose of antibodies derived from donated plasma. Administered intravenously, it helps decrease inflammation in blood vessels.

Aspirin

• High-dose aspirin is given during the acute phase to reduce inflammation and prevent blood clots. Once the fever subsides, the aspirin dose is reduced to a lower maintenance level.

Anticoagulants

• If there is a high risk of blood clot formation, blood thinners such as heparin may be prescribed.

Other Medications

• Ciclosporine A and Methotrexate are occasionally used in Kawasaki disease treatment, though ciclosporine A is used less frequently, and methotrexate does not have broad support from the American Heart Association due to limited evidence of its effectiveness.

If not treated properly or left untreated, Kawasaki disease can lead to serious complications, particularly affecting the heart and coronary arteries. Some potential complications include:

Heart Complications

• Coronary Artery Abnormalities: These include aneurysms, which are weakened spots in the coronary artery walls.
• Myocarditis: Inflammation of the heart muscle, which can reduce heart function.
• Heart Valve Problems: Kawasaki disease may affect heart valves, leading to conditions like valve regurgitation (leakage) or stenosis (narrowing).
• Pericarditis: Inflammation of the pericardium, the sac surrounding the heart.
• Blood Vessel Inflammation: Inflammation can also occur in other blood vessels, affecting organs such as the kidneys, liver, and lungs.

Neurological Complications

• These can include irritability, headaches, seizures, and changes in consciousness. Rare cases may involve facial paralysis or even stroke.

Renal Complications

• Kawasaki disease can cause kidney inflammation, leading to abnormal kidney function and sometimes resulting in blood or protein in the urine.

Hematological Complications

• These include low platelet levels (thrombocytopenia) or elevated white blood cell counts.

In addition to conventional treatments, some complementary therapies have shown promise in managing Kawasaki disease symptoms. These include:

Corticosteroid Therapy

• Steroids may be used for persistent fever or inflammation, particularly when IVIG treatment alone is not effective. Methylprednisolone is used for severe inflammation.

Chinese Herbal Medicine

• Some plant-based treatments have been explored for Kawasaki disease and may be used alongside conventional therapies. Though generally considered safe, more research is needed to confirm their effectiveness.

Although Kawasaki disease requires medical attention and supervision by healthcare providers, there are several steps you can take at home to ensure your child's comfort and support their recovery. Here are some home care suggestions:

Provide Comfort Measures

• Create a peaceful, cool, and restful environment for your child. Dress them in loose, comfortable clothing and use light bedding. Ensure the room is well-ventilated and the temperature is comfortable.

Keep Them Hydrated

• Encourage your child to drink plenty of fluids to stay hydrated. Offer water, diluted juices, or electrolyte drinks. If your child’s appetite is low, provide small, frequent meals and snacks.

Prioritize Rest and Activity

• Rest is crucial for healing, so ensure your child gets enough sleep and avoids strenuous activities. Light physical activity, like short walks or gentle play, may be beneficial if tolerated and approved by the doctor.

Focus on Skincare

• If your child’s skin begins to peel on the hands and feet during recovery, apply moisturizers to soothe dryness. This will help alleviate discomfort and aid in skin healing.

Although Kawasaki disease is an acute illness, children who have had it may require long-term monitoring. According to the American Heart Association (AHA), the recommended follow-up for Kawasaki disease includes:

Baseline and Follow-Up Echocardiography

• Initial echocardiograms should be done during the acute phase. Additional echocardiograms are recommended at 2 weeks and 6-8 weeks after the onset of the disease. Children at high risk or with slow recovery may need more frequent imaging.

For Low-Risk Children

• Follow-up is advised for 10-20 years, even if no coronary abnormalities are found.

For Moderate-Risk Children

• If aneurysms regress by weeks 6-8, treat as low-risk. Cardiac evaluations every 3-5 years are recommended.

For High-Risk Children

• These children may have a higher chance of developing coronary artery stenosis (narrowing or blockage of the coronary artery). Comprehensive cardiac exams twice a year and annual stress tests or perfusion studies are suggested. Physical activity should be limited based on bleeding risk, and angiography may be needed in some cases.